CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,343,575 | +37.4% | 1,957,687 | +12.2% | 0.01% | +20.0% |
| Q2 2023 | $38,821,591 | -0.1% | 1,744,790 | -2.7% | 0.01% | 0.0% |
| Q1 2023 | $38,856,474 | +111036.0% | 1,793,927 | +4.2% | 0.01% | 0.0% |
| Q4 2022 | $34,963 | -99.9% | 1,721,501 | +4.5% | 0.01% | -16.7% |
| Q3 2022 | $42,223,000 | +9.0% | 1,646,783 | +1.1% | 0.01% | 0.0% |
| Q2 2022 | $38,748,000 | +3.2% | 1,629,477 | -2.2% | 0.01% | +20.0% |
| Q1 2022 | $37,538,000 | +9.5% | 1,666,880 | -3.7% | 0.01% | +25.0% |
| Q4 2021 | $34,271,000 | -3.5% | 1,730,872 | -4.1% | 0.00% | -20.0% |
| Q3 2021 | $35,530,000 | -10.7% | 1,805,405 | -0.2% | 0.01% | 0.0% |
| Q2 2021 | $39,804,000 | -5.5% | 1,809,310 | +2.2% | 0.01% | -16.7% |
| Q1 2021 | $42,136,000 | -2.2% | 1,771,205 | +7.5% | 0.01% | -14.3% |
| Q4 2020 | $43,093,000 | +63.7% | 1,647,323 | +8.9% | 0.01% | +40.0% |
| Q3 2020 | $26,318,000 | +2.7% | 1,512,125 | -0.8% | 0.01% | 0.0% |
| Q2 2020 | $25,632,000 | +45.7% | 1,523,954 | +3.0% | 0.01% | 0.0% |
| Q1 2020 | $17,587,000 | -49.3% | 1,479,261 | -48.4% | 0.01% | +25.0% |
| Q4 2019 | $34,668,000 | +73.2% | 2,865,212 | +102.3% | 0.00% | -20.0% |
| Q3 2019 | $20,020,000 | +29.7% | 1,416,399 | +2.3% | 0.01% | +25.0% |
| Q2 2019 | $15,436,000 | +4.4% | 1,384,472 | +9.9% | 0.00% | 0.0% |
| Q1 2019 | $14,787,000 | -52.9% | 1,259,569 | -46.4% | 0.00% | -20.0% |
| Q4 2018 | $31,396,000 | +105.6% | 2,350,068 | +115.7% | 0.01% | +25.0% |
| Q3 2018 | $15,272,000 | -0.8% | 1,089,329 | +11.3% | 0.00% | -20.0% |
| Q2 2018 | $15,392,000 | +6.5% | 979,159 | +11.5% | 0.01% | 0.0% |
| Q1 2018 | $14,447,000 | -15.4% | 878,255 | -7.1% | 0.01% | -16.7% |
| Q4 2017 | $17,072,000 | -8.1% | 945,350 | -1.8% | 0.01% | -14.3% |
| Q3 2017 | $18,584,000 | +82.2% | 962,957 | +11.4% | 0.01% | +75.0% |
| Q2 2017 | $10,198,000 | +10.8% | 864,322 | +2.9% | 0.00% | 0.0% |
| Q1 2017 | $9,207,000 | +66.4% | 840,195 | +10.2% | 0.00% | +33.3% |
| Q4 2016 | $5,533,000 | +28.5% | 762,250 | +15.0% | 0.00% | +50.0% |
| Q3 2016 | $4,307,000 | +46.7% | 662,772 | +23.2% | 0.00% | 0.0% |
| Q2 2016 | $2,935,000 | +26.9% | 537,798 | +8.8% | 0.00% | +100.0% |
| Q1 2016 | $2,312,000 | -6.1% | 494,148 | -0.0% | 0.00% | 0.0% |
| Q4 2015 | $2,461,000 | +35.4% | 494,339 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $1,817,000 | -32.1% | 483,620 | +8.6% | 0.00% | -50.0% |
| Q2 2015 | $2,676,000 | +8.0% | 445,473 | +0.6% | 0.00% | +100.0% |
| Q1 2015 | $2,478,000 | +96.8% | 442,751 | +5.4% | 0.00% | 0.0% |
| Q4 2014 | $1,259,000 | +4.0% | 420,143 | -7.0% | 0.00% | 0.0% |
| Q3 2014 | $1,210,000 | +4.6% | 451,775 | +9.2% | 0.00% | 0.0% |
| Q2 2014 | $1,157,000 | -24.7% | 413,564 | +17.4% | 0.00% | 0.0% |
| Q1 2014 | $1,536,000 | +61.0% | 352,384 | +18.9% | 0.00% | 0.0% |
| Q4 2013 | $954,000 | +155.8% | 296,476 | +26.3% | 0.00% | – |
| Q3 2013 | $373,000 | -5.1% | 234,818 | +3.3% | 0.00% | – |
| Q2 2013 | $393,000 | – | 227,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |